Comparative Pharmacology
Head-to-head clinical analysis: ACETADOTE versus CYANOKIT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACETADOTE versus CYANOKIT.
ACETADOTE vs CYANOKIT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetylcysteine serves as a precursor to glutathione, replenishing hepatic glutathione stores and enhancing the detoxification of the toxic metabolite N-acetyl-p-benzoquinoneimine (NAPQI) in acetaminophen overdose.
Hydroxocobalamin, a form of vitamin B12, acts as a scavenger of cyanide ions by binding with them to form cyanocobalamin, which is then excreted in urine. It has a higher affinity for cyanide than cytochrome c oxidase, thereby restoring mitochondrial function.
Intravenous loading dose of 150 mg/kg over 60 minutes, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (total 300 mg/kg over 21 hours). Oral: 140 mg/kg loading dose, then 70 mg/kg every 4 hours for 17 doses.
5 g intravenous infusion over 15 minutes for adults and pediatric patients weighing >=40 kg. A second dose of 5 g may be administered if needed based on clinical response.
None Documented
None Documented
Terminal elimination half-life: 5.6 hours (range 4.1-7.6). In acetaminophen overdose, half-life may be prolonged (up to 20 hours) due to saturation of metabolic pathways.
The terminal elimination half-life of hydroxocobalamin is approximately 24-28 hours in healthy adults; in cyanide poisoning, the half-life may be prolonged due to reversible binding to cyanide.
Renal: 60-80% as unchanged drug and metabolites (sulfate, glucuronide, cysteine, N-acetylcysteine conjugates). Fecal: minor (less than 3%).
Primarily renal elimination as hydroxocobalamin and cyanocobalamin; >90% of an intravenous dose is excreted in urine within 72 hours, with the remainder eliminated in feces via biliary excretion.
Category C
Category C
Antidote
Antidote